WebDisclosure WebDisclosure
Basculer en Français
10411 Companies
217812 Keywords
147362 Articles
115250 Press releases
Headlines Articles Press releases ABIONYX Remove
  1. Home
  2. Companies
  3. ABIONYX
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 06/13/2024 at 19:53, 1 year 11 months ago

    ABIONYX Pharma Receives FDA Approval for New Sepsis Study

    FDA Clinical Study ABIONYX Pharma Sepsis CER-001
  • PRESS RELEASE

    published on 06/13/2024 at 19:48, 1 year 11 months ago

    Informations privilégiées / Autres communiqués

    ABIONYX Pharma a passé avec succès la réunion pré-IND avec la FDA pour une étude clinique de phase 2b/3 évaluant CER-001 dans le traitement de patients atteints de sepsis. La société se prépare à déposer une demande d’IND pour lancer l'étude clinique
    FDA ABIONYX Pharma Sepsis CER-001 Réunion Pré-IND
    Logo of ABIONYX
  • PRESS RELEASE

    published on 06/13/2024 at 19:48, 1 year 11 months ago

    Inside Information / Other news releases

    ABIONYX Pharma completes successful pre-IND meeting with the FDA for CER-001 Phase 2b/3 Clinical Trial in Sepsis, marking significant progress in developing innovative therapy
    FDA ABIONYX Pharma Sepsis CER-001 Pre-IND Meeting
    Logo of ABIONYX
Previous page
1 ... 14 15
Accesswire
  • Published on 05/16/2026 at 01:15, 1 day 5 hours ago

    Findev Inc. Announces a New Member of the Board of Directors

  • Published on 05/16/2026 at 01:00, 1 day 5 hours ago

    Arctic Fox Adopts Semi-Annual Reporting

  • Published on 05/16/2026 at 00:00, 1 day 6 hours ago

    Onco-Innovations Strengthens Quality Testing for Lead PNKP Inhibitor Drug Candidate

  • Published on 05/15/2026 at 23:10, 1 day 7 hours ago

    Golden Minerals Reports First Quarter 2026 Financial Results

  • Published on 05/15/2026 at 23:00, 1 day 7 hours ago

    Jericho Energy Ventures Announces Transition to Semi-Annual Reporting to Enhance Efficiency

View all ACCESSWIRE
EQS Group
  • Published on 05/16/2026 at 16:08, 14 hours 38 minutes ago

    The publication of the audited financial statements for 2025 will be postponed to 12 June 2026 – management does not expect any significant changes to the figures already published

  • Published on 05/15/2026 at 20:10, 1 day 10 hours ago

    CPIPG Communication Concerning Voluntary Offer on NEXT RE Shares – Provisional Results Announcement

  • Published on 05/15/2026 at 18:30, 1 day 12 hours ago

    Designated Person Notifications

  • Published on 05/15/2026 at 18:30, 1 day 12 hours ago

    Designated Person Notifications

  • Published on 05/15/2026 at 18:10, 1 day 12 hours ago

    Virtual Science AI launches first AI-driven competitor activity tracking platform to support pharma asset launch success

View all EQS
Les Echos
  • Published on 05/15/2026 at 15:08, 1 day 15 hours ago

    Notice of exercise of early redemption option of the subordinated note ISIN : FR0010203026

  • Published on 05/15/2026 at 15:00, 1 day 15 hours ago

    Exercice de l’option de remboursement de l'instrument subordonné FR0010203026

  • Published on 05/15/2026 at 10:09, 1 day 20 hours ago

    Groupe Crit : Modalités de mise à disposition des documents préparatoires à l’Assemblée Générale Mixte du 05 juin 2026.

  • Published on 05/14/2026 at 09:03, 2 days 21 hours ago

    Coup d'envoi pour les carrières dans l'esport : 65% de la population mondiale réclame plus de formations et de parcours professionnels pour le jeu vidéo de compétition

  • Published on 05/13/2026 at 18:02, 3 days 12 hours ago

    ALTAREA : Assemblée Générale Mixte du 4 juin 2026 MODALITES DE MISE A DISPOSITION DES DOCUMENTS PREPARATOIRES

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy